U.S. Food and Drug Administration
-
FDA Grants Historic Approval for Gene-Editing Treatment in Sickle Cell Disease
-
FDA Raises Alarm: WanaBana Fruit Pouches Pose Potential Lead Hazard for Kids
-
Popular OTC Allergy, Cold Medicine Ingredient is Just Waste of Money: FDA Panel
-
FDA Recently Approves the World's Most Expensive Drug - Worth $3.5 Million!
-
FDA Approves Tzield, First Drug That Delays Type 1 Diabetes Progression
-
U.S. FDA Panel Addresses Oximeter's Effectivity on Darker Skin Tones as 'Critical' Amidst COVID-19
-
Check Your Sunscreens Now: Valisure Warns FDA, Suggests High Levels of Cancer-Causing Substance on Skincare Products
-
First Long-Acting HIV Two-Shot Combo Gets FDA Approval Aimed to Help Patients Track Medication Better
-
WHO Casts Doubts on Remdesivir's Effectiveness Against COVID-19; Goes Against FDA's Recommendations
-
COVID-19 Cure Update: U.S. FDA OKs Issuing Emergency Authorization to Use Injected Drug Remdesivir as Cure to Patients with Coronavirus
-
FDA Says Yes to Coronavirus Cure From Israel; US Gov't Ready to Test Trial Medicine Starting Next Week
-
World's Most Expensive Gene Therapy Zolgensma Treats Rare Genetic Disease In Infants
Most Popular
